NASDAQ:VYGR
Voyager Therapeutics Stock News
$8.43
-0.200 (-2.32%)
At Close: May 17, 2024
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Voyager Therapeutics, Inc. ("Voyager" or "the Company") (NASDAQ: VYG
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
04:01pm, Tuesday, 02'nd Feb 2021
CAMBRIDGE, Mass., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) today announced that Neurocrine Biosciences, Inc. (Nasdaq: NBIX) provided notice of termination of the Par
NEW YORK, Jan. 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Voyager Ther
LOS ANGELES, Jan. 27, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Voyager Therapeutics, Inc. ("Voyag
LOS ANGELES--(BUSINESS WIRE)---- $VYGR #VYGR--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc.
New York, New York--(Newsfile Corp. - January 26, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Voyager Therapeutics, Inc. ("Voyager" or the "Company") (NASDAQ: VY
Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Voyager Therapeutics, Inc. ("Voya
Shareholder Alert: Robbins LLP Announces That Voyager Therapeutics, Inc. (VYGR) is Being Sued for Misleading Shareholders
02:19pm, Monday, 25'th Jan 2021
SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $VYGR #ClassAction--Voyager Therapeutics, Inc. (VYGR) Misled Shareholders Regarding the Viability of its Lead Clinical Candidate for Huntington's Dise
LOS ANGELES--(BUSINESS WIRE)---- $VYGR #VYGR--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc.
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Voyager Therapeutics, Inc. (NA
Pomerantz Law Firm Announces the Filing of a Class Action against Voyager Therapeutics, Inc. and Certain Officers - VYGR
12:20am, Saturday, 23'rd Jan 2021
NEW YORK, Jan. 23, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Voyager Therapeutics, Inc. ("Voyager" or the "Company") (NASDAQ: VYGR) and certain of
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:03pm, Monday, 11'th Jan 2021
CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurologi
Is the Options Market Predicting a Spike in Voyager (VYGR) Stock?
10:32am, Monday, 11'th Jan 2021
Investors need to pay close attention to Voyager (VYGR) stock based on the movements in the options market lately.
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
04:17pm, Tuesday, 22'nd Dec 2020
CAMBRIDGE, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) today announced that the U.S. Food and Drug Administration (FDA) has notified Neurocrine Biosciences (Nasd
Voyager (VYGR) in Focus: Stock Moves 5.7% Higher
09:47am, Tuesday, 22'nd Dec 2020
Voyager (VYGR) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
